| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.088 | 0.06 |